Johnson & Johnson
JNJLast close · Oct 16, 2026255.56+2.28 (+0.90%)
Market cap$615.9B
Between Apr 23, 2026 and Sep 8, 2026, Johnson & Johnson (JNJ) insiders filed 40 Form 4 transactions: 11 sales worth $70.2M in total and no open-market purchase. The largest seller was Duato Joaquin, $26.7M. 29 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
0
11
0
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Pinto Daniel E | Director | A | 113 | 276.31 | $31,250.1 | |
| 2026-09-08 | Woods Eugene A. | Director | A | 136 | 276.31 | $37,500 | |
| 2026-09-08 | HEWSON MARILLYN A | Director | A | 181 | 276.31 | $50,000 | |
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | M | 11,070 | 131.94 | $1.5M | |
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | S | 11,070 | 274.74 | $3.0M | |
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | M | 22,527 | 151.41 | $3.4M | |
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | S | 22,527 | 274.74 | $6.2M | |
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | M | 11,070 | 0.00 | $0 | |
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | M | 22,527 | 0.00 | $0 | |
| 2026-08-17 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | 15,000 | 115.67 | $1.7M | |
| 2026-08-17 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | S | 15,000 | 263.36 | $4.0M | |
| 2026-08-17 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | 15,000 | 0.00 | $0 | |
| 2026-08-13 | Duato Joaquin | CEO and Chairman of the Board | M | 123,291 | 115.67 | $14.3M | |
| 2026-08-13 | Duato Joaquin | CEO and Chairman of the Board | S | 20,976 | 262.00 | $5.5M | |
| 2026-08-13 | Duato Joaquin | CEO and Chairman of the Board | S | 102,315 | 261.00 | $26.7M | |
| 2026-08-13 | Duato Joaquin | CEO and Chairman of the Board | M | 123,291 | 0.00 | $0 | |
| 2026-08-05 | Duato Joaquin | CEO and Chairman of the Board | S | 41,957 | 258.06 | $10.8M | |
| 2026-08-05 | Duato Joaquin | CEO and Chairman of the Board | S | 6,523 | 258.74 | $1.7M | |
| 2026-08-06 | Forminard Elizabeth | EVP, Chief Legal Officer | M | 9,344 | 131.94 | $1.2M | |
| 2026-08-06 | Forminard Elizabeth | EVP, Chief Legal Officer | S | 9,344 | 257.76 | $2.4M | |
| 2026-08-06 | Forminard Elizabeth | EVP, Chief Legal Officer | S | 6,574 | 255.93 | $1.7M | |
| 2026-08-06 | Forminard Elizabeth | EVP, Chief Legal Officer | M | 9,344 | 0.00 | $0 | |
| 2026-07-20 | Broadhurst Vanessa | EVP, Global Corp Affairs | M | 11,129 | 129.51 | $1.4M | |
| 2026-07-20 | Broadhurst Vanessa | EVP, Global Corp Affairs | M | 11,925 | 131.94 | $1.6M | |
| 2026-07-20 | Broadhurst Vanessa | EVP, Global Corp Affairs | S | 23,054 | 251.27 | $5.8M | |
| 2026-07-20 | Broadhurst Vanessa | EVP, Global Corp Affairs | M | 11,129 | 0.00 | $0 | |
| 2026-07-20 | Broadhurst Vanessa | EVP, Global Corp Affairs | M | 11,925 | 0.00 | $0 | |
| 2026-06-11 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | 10,000 | 115.67 | $1.2M | |
| 2026-06-11 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | S | 10,000 | 241.15 | $2.4M | |
| 2026-06-11 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | 10,000 | 0.00 | $0 | |
| 2026-06-09 | Woods Eugene A. | Director | A | 161 | 232.79 | $37,499.9 | |
| 2026-06-09 | Pinto Daniel E | Director | A | 134 | 232.79 | $31,250 | |
| 2026-06-09 | HEWSON MARILLYN A | Director | A | 215 | 232.79 | $50,000 | |
| 2026-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | M | 25,255 | 0.00 | $0 | |
| 2026-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | F | 11,002 | 229.85 | $2.5M | |
| 2026-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | M | 25,255 | 0.00 | $0 | |
| 2026-04-23 | Woods Eugene A. | Director | A | 975 | 0.00 | $0 | |
| 2026-04-23 | West Nadja | Director | A | 975 | 0.00 | $0 | |
| 2026-04-23 | WEINBERGER MARK A | Director | A | 975 | 0.00 | $0 | |
| 2026-04-23 | Pinto Daniel E | Director | A | 1,712 | 0.00 | $0 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.